141 related articles for article (PubMed ID: 9608825)
21. [Should arterial gas values be improved in patients with chronic bronchitic respiratory insufficiency? Value of almitrine dimesylate].
Prefaut C
Presse Med; 1984 Oct; 13(34):2090-3. PubMed ID: 6149537
[TBL] [Abstract][Full Text] [Related]
22. Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease.
Watanabe S; Kanner RE; Cutillo AG; Menlove RL; Bachand RT; Szalkowski MB; Renzetti AD
Am Rev Respir Dis; 1989 Nov; 140(5):1269-73. PubMed ID: 2683905
[TBL] [Abstract][Full Text] [Related]
23. [Eight years of experience in Warsaw with domiciliary long term oxygen therapy].
Tobiasz M; Sliwiński P; Górecka D; Gorzelak K; Zieliński J
Pneumonol Alergol Pol; 1996; 64(9-10):568-76. PubMed ID: 8991552
[TBL] [Abstract][Full Text] [Related]
24. Sequential treatment with low dose almitrine bismesylate in hypoxaemic chronic obstructive airways disease.
Bardsley PA; Howard P; Tang O; Empey D; Harrison B; Peake MD; O'Reilly J; Riordan JF; Wilkinson J; Arnaud F
Eur Respir J; 1992 Oct; 5(9):1054-61. PubMed ID: 1426214
[TBL] [Abstract][Full Text] [Related]
25. The effect of long-term almitrine therapy on sleep hypoxaemia in patients with chronic airways obstruction.
Racineux JL; Meslier N; Hubert P
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():183s-184s. PubMed ID: 3690029
[TBL] [Abstract][Full Text] [Related]
26. Intravenous almitrine bismesylate reversibly induces lactic acidosis and hepatic dysfunction in patients with acute lung injury.
B'chir A; Mebazaa A; Losser MR; Romieu M; Payen D
Anesthesiology; 1998 Oct; 89(4):823-30. PubMed ID: 9777998
[TBL] [Abstract][Full Text] [Related]
27. Long-term oxygen therapy in COPD: evidences and open questions of current indications.
Corrado A; Renda T; Bertini S
Monaldi Arch Chest Dis; 2010 Mar; 73(1):34-43. PubMed ID: 20499792
[TBL] [Abstract][Full Text] [Related]
28. Effect of almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease.
Saadjian AY; Philip-Jöel FF; Barret A; Levy S; Arnaud AG
Eur Respir J; 1994 May; 7(5):862-8. PubMed ID: 8050541
[TBL] [Abstract][Full Text] [Related]
29. [Oxygen therapy undisputed in severe, but doubtful in moderate, hypoxia. Comment to meta-analysis of home oxygen therapy in chronic obstructive lung disease].
Ström K
Lakartidningen; 2001 Jan; 98(4):295-8. PubMed ID: 11271560
[TBL] [Abstract][Full Text] [Related]
30. [Sleep and nocturnal desaturation of patients with chronic obstructive bronchopneumopathies. Effects of almitrine bismesylate administered orally].
Kurtz D; Weitzenblum E; Krieger J; Reitzer B; Roujansky P
Rev Mal Respir; 1985; 2 Suppl 1():S45-52. PubMed ID: 2870547
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of the effects of almitrine bismesylate and lateral position during unilateral bacterial pneumonia with severe hypoxemia.
Dreyfuss D; Djedaini K; Lanore JJ; Mier L; Froidevaux R; Coste F
Am Rev Respir Dis; 1992 Aug; 146(2):295-9. PubMed ID: 1489115
[TBL] [Abstract][Full Text] [Related]
32. [Effects of home oxygen therapy on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease].
Tobiasz M
Pol Arch Med Wewn; 1995 Jun; 93(6):498-508. PubMed ID: 7491350
[TBL] [Abstract][Full Text] [Related]
33. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
Voisin C; Howard P; Ansquer JC
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
[TBL] [Abstract][Full Text] [Related]
34. Effects of long-term oxygen therapy on mortality and morbidity.
Criner GJ
Respir Care; 2000 Jan; 45(1):105-18. PubMed ID: 10771786
[TBL] [Abstract][Full Text] [Related]
35. Comparison of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep in patients with chronic obstructive lung disease.
Daskalopoulou E; Patakas D; Tsara V; Zoglopitis F; Maniki E
Thorax; 1990 Sep; 45(9):666-9. PubMed ID: 2145654
[TBL] [Abstract][Full Text] [Related]
36. Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease.
Bardsley PA; Howard P; DeBacker W; Vermeire P; Mairesse M; Ledent C; Radermecker M; Bury T; Ansquer J
Eur Respir J; 1991 Mar; 4(3):308-10. PubMed ID: 1907566
[TBL] [Abstract][Full Text] [Related]
37. Selection of patients for long-term oxygen therapy (LTO).
Levi-Valensi P; Aubry P; Rida Z; Rose D; Ndarurinze S; Jounieaux V
Eur Respir J Suppl; 1989 Jul; 7():624s-629s. PubMed ID: 2508650
[TBL] [Abstract][Full Text] [Related]
38. Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency.
Bakran I; Vrhovac B; Stangl B; Tabori D; Ivicevic A; Todic V; Kandare F
Eur J Clin Pharmacol; 1990; 38(3):249-53. PubMed ID: 2187700
[TBL] [Abstract][Full Text] [Related]
39. [Almitrine: a peripheral respiratory stimulant in chronic obstructive pulmonary disease].
Rubio Terrés C; López Alvarez M; Vargas Castrillón E
Rev Clin Esp; 1990 Feb; 186(2):84-7. PubMed ID: 2158666
[TBL] [Abstract][Full Text] [Related]
40. Dose-response and pharmacokinetic study with almitrine bismesylate after single oral administrations in COPD patients.
Bury T; Jeannot JP; Ansquer JC; Radermecker M
Eur Respir J; 1989 Jan; 2(1):49-55. PubMed ID: 2495983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
